Contributors to white matter damage in the frontal lobe in Alzheimer's disease
- 6 October 2005
- journal article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 31 (6), 623-631
- https://doi.org/10.1111/j.1365-2990.2005.00678.x
Abstract
Abnormalities of cerebral white matter are present in a majority of patients with Alzheimer's disease (AD) and probably contribute to motor dysfunction and cognitive impairment. The white matter abnormalities are usually attributed to degenerative vascular disease and cerebral amyloid angiopathy (CAA) but the evidence is scanty or inconclusive. In the present study we examined sections of frontal lobe from 125 autopsy-confirmed cases of AD and assessed the relationship of degenerative large and small vessel disease, CAA, parenchymal Abeta load and APOE genotype, to several objective measures of white matter damage: extent of immunolabelling for glial fibrillary acidic protein (GFAP), axonal accumulation of amyloid precursor protein (APP), axon density in superficial and deep white matter, and intensity of staining for myelin. We found no association between atherosclerosis, arteriolosclerosis, CAA or APOE genotype and white matter damage. However, labelling of white matter for GFAP correlated strongly with the parenchymal Abeta load (P = 0.0003) and with APP accumulation (P = 0.008). Our findings suggest that severity of frontal white matter damage in AD is closely related to parenchymal Abeta load and that in most cases the contribution of degenerative vascular disease, CAA and APOE is relatively minorKeywords
This publication has 67 references indexed in Scilit:
- Clinical manifestations of cerebral amyloid angiopathy–related inflammationAnnals of Neurology, 2004
- APOEɛ4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ proteinNeuropathology and Applied Neurobiology, 2003
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Effect of the Apolipoprotein E ε4 Allele on White Matter Hyperintensities in DementiaStroke, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- White Matter Lesions in Alzheimer Patients Are Influenced by Apolipoprotein E GenotypeDementia and Geriatric Cognitive Disorders, 1999
- The Effect of White Matter Low Attenuation on Cognitive Performance in Dementia of the Alzheimer TypeAge and Ageing, 1996
- Apolipoprotein E ε4 Is Associated With the Presence and Earlier Onset of Hemorrhage in Cerebral Amyloid AngiopathyStroke, 1996
- Correlations of synaptic and pathological markers with cognition of the elderlyNeurobiology of Aging, 1995
- Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery diseaseThe American Journal of Cardiology, 1993